Breast Cancer (Genetics)

Patent Issued for Breast Cancer Protein, Mammaglobin

Published in Women's Health Weekly, February 8th, 1999

Corixa Corporation, a research-based biotechnology company, announced that the United States Patent and Trademark Office has issued a patent to Washington University in St. Louis, Missouri, licensed exclusively worldwide to Corixa, for the breast cancer protein, mammaglobin.

Mammaglobin is expressed in the adult mammary gland and has been shown to be differentially expressed in numerous breast carcinoma cell lines and in primary and metastatic human breast tumors. The breast-specific expression of mammaglobin and its marked over-expression in breast cancer specimens suggest that mammaglobin potentially could be used as a tumor vaccine antigen and as an effective marker...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1999-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry